Georgia Life Sciences: Growth, Investment, and Future Potential

Hypepotamus: Georgia Life Sciences: Growth, Investment, and Future Potential

Maija Ehlinger: February 14, 2025

Georgia Life Sciences: Growth, Investment, and Future Potential - Hypepotamus




For the last 35 years, Georgia Bio, the state’s main advocacy and business leadership organization, has worked to support pharmaceuticals, biotech startups, medical device companies, universities, research institutes, and government groups who are growing in the Peach State.


The organization recently announced a rebrand with its new name, Georgia Life Sciences. The name better reflects the organization’s “renewed focus and support” for the state’s growing life sciences community, CEO Maria Thacker Goethe told Hypepotamus.

 


The State of Life Sciences In Georgia


Close to 4,000 life sciences companies are building in the State of Georgia currently, and the industry is the “highest paying and fastest growing [sector] in the state,” according to Thacker Goethe.


“Georgia’s sizable, fast-growing, and high paying life sciences sector is critical to our economic growth. Surrounding states, and beyond, have prioritized and continue to invest in life sciences for many reasons, in large part because relative to other industrial sectors, the extended domestic supply chain of the U.S. industrial bioeconomy generates outsized secondary economic benefits,” she added. “The industry provides a strong mix of scientific and production jobs providing varied employment opportunities, and the biggest gap in the sector’s workforce require a technical degree or even some basic certifications out of high school. Life sciences is a very large sector that encompasses human health but also industrial bioproducts, biofuels, biofeedstocks, medical devices, and much more. According to BIO’s 2024 Economic Impact study, Georgia is in the top 10 states for this sector, and if we can make some progress to grow economic incentives and train our workforce, we will continue to be a leader.”


Georgia’s growing success in the life sciences stems from the state’s academic research institutions, substantial corporate investment, and strategic economic development initiatives.“Georgia is becoming a critical player in biopharma manufacturing,” Thacker Goethe told Hypepotamus, highlighting the presence of industry giants like Takeda, Boehringer Ingelheim, and Johnson & Johnson.


She also pointed to the state’s expanding medical device and diagnostics sectors, thanks to close collaborations with research powerhouses like Georgia Tech and Emory University. The state’s agricultural roots also provide fertile ground for the ‘agbio’ sector, with institutions like the University of Georgia conducting new research in precision agriculture and crop resilience.


When asked to describe the state of the life sciences’ community in Georgia, Thacker Goethe emphasized the state’s potential in becoming a hub for regenerative medicine companies, smart medical devices, and CDMOs (Contract Development and Manufacturing Organizations).


“With increasing demand for renewable materials and biofuels, Georgia’s industrial biotech sector should expand rapidly, leveraging its agricultural strengths and infrastructure. Breakthroughs in CRISPR-based crop modifications may drive Georgia’s role in creating resilient, high-yield crops to combat climate change and food security challenges,” she added.



Potential For Local Growth


But challenges remain.


Access to capital is a primary concern. While venture capital is increasing, securing adequate funding for life sciences startups can be difficult. Thacker Goethe pointed out the need for more wet-lab spaces, incubators, and biomanufacturing facilities to accommodate growing companies. She also warned that neighboring states are making targeted investments in life sciences and could potentially narrow the gap.


“One challenge we are working to address: building a community coalition to establish a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) matching grants program in Georgia. We are the only state in the southeast that does not have this program (Alabama established theirs a couple of years ago),” she added. “The federal SBIR/STTR program provides early funding for research and development. However, these grants often don’t cover later-stage activities like prototyping, manufacturing, regulatory approvals, or market entry. State matching programs provide the additional capital needed to help startups move beyond research and into product development and commercialization, enabling companies to bring innovative solutions to market faster. We will lose Georgia-grown innovations to others states if we are unable to adopt a matching program.”


National headwinds can also hamper industry growth, according to a recent statement Georgia Life Sciences published around the recent National Institutes of Health (NIH) guidance to limit funding for medical and life sciences research at universities. 

You can read the full statement here.

Georgia Life Sciences Applauds Congressman McCormick for Introducing Federal Biotech Leadership Legislation

July 24, 2026
July 24, 2026, Atlanta, GA - Georgia Life Sciences applauds Congressman Rich McCormick (R-GA) for introducing the Biotechnology Diplomacy Leadership Act , legislation designed to strengthen America's leadership in biotechnology by establishing a senior biotechnology leadership position within the U.S. Department of State. As biotechnology continues to drive breakthroughs in healthcare, agriculture, advanced manufacturing, and national security, the United States must remain a global leader in innovation while strengthening strategic partnerships with allies around the world. The proposed legislation recognizes biotechnology as a critical component of U.S. economic competitiveness and foreign policy and would help ensure that the federal government is well positioned to advance these priorities internationally. The legislation also reflects recommendations from the National Security Commission on Emerging Biotechnology , which called for a more coordinated national approach to advancing biotechnology and protecting U.S. leadership in this strategically important sector. "Georgia is home to one of the nation's fastest-growing life sciences ecosystems, and policies that strengthen America's global biotechnology leadership directly benefit innovators, researchers, manufacturers, and patients," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "We appreciate Congressman McCormick's leadership in recognizing biotechnology as both an economic engine and a strategic national priority." Georgia Life Sciences looks forward to working with policymakers at both the federal and state levels to advance policies that foster innovation, strengthen the U.S. bioeconomy, and ensure America remains the global leader in biotechnology.

Georgia Life Sciences Names Renee' Martin, Ph.D., Program Manager to Lead Flagship Educator Workforce Development Program

July 21, 2026
Georgia Life Sciences names Renee Martin, Ph.D., to lead its Teacher Training Initiative, advancing educator workforce development and Georgia's future life sciences talent pipeline.

Georgia Life Sciences Partnership Expands Plant Biotechnology Education for Agriscience Teachers Across Georgia

July 17, 2026
FOR IMMEDIATE RELEASE  July 16, 2026 ATLANTA, Ga . – Eighteen Georgia high school agriscience teachers recently participated in a hands-on plant tissue culture training at Cedar Shoals High School in Athens, equipping educators with biotechnology skills and classroom resources that will expand access to experiential STEM learning for students across the state. Hosted through a partnership led by Georgia Life Sciences (GLS), the workshop was facilitated by Julie Throne, Agriscience Teacher, FFA Advisor, and CTAE Department Chair at Cedar Shoals High School. Participants received practical instruction in plant tissue culture techniques using newly developed portable tissue culture kits generously donated by California-based Athena Ag. Plant tissue culture is a foundational biotechnology technique used in agriculture and plant science research to propagate plants under aseptic conditions. By incorporating these concepts into agriscience classrooms, educators can provide students with hands-on experiences that introduce biotechnology while building technical skills relevant to careers in agriculture and biotechnology. As part of the workshop, each participating teacher received two complete plant tissue culture kits to take back to their school, enabling students throughout Georgia to engage in laboratory-based biotechnology activities and explore emerging career pathways in the life sciences. "Providing educators with access to industry-relevant training and classroom resources is one of the most effective ways to inspire the next generation of Georgia's life sciences workforce," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "Through partnerships like this, we're helping teachers bring real-world biotechnology into their classrooms while expanding opportunities for students to discover careers in one of Georgia's fastest-growing industries." The training is part of Georgia Life Sciences' broader Teacher Training Initiative, a statewide workforce development program that equips middle and high school educators with the knowledge, tools, and industry connections needed to deliver hands-on biotechnology instruction. Through strategic partnerships with industry, education, and nonprofit organizations, the initiative continues to strengthen Georgia's talent pipeline by connecting classroom learning with real-world workforce opportunities. Georgia Life Sciences extends its appreciation to Julie Throne for leading the training and to Athena for its generous donation of classroom kits, helping expand access to biotechnology education for educators and students across the state.
MORE POSTS